Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04141 (
granulocyte-macrophage colony-stimulating factor
)
6,790
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The highly regulated enzyme HMG-CoA reductase generates mevalonate, the precursor of a complex series of isoprenoids that posttranslationally modify (isoprenylate) certain proteins (e.g., the low-molecular-weight GTP-binding proteins) or that are incorporated into cholesterol and other end products. We recently reported that isoprenoids are required for NADPH oxidase activity in granulocytes via LMW GTP-binding protein isoprenylation. In this study, we evaluated the effects of isoprenoid depletion on the expression of proinflammatory genes in human monocytic THP-1 cells. We selected conditions under which pretreatment for 24 h with isoprenoid synthesis inhibitors (HMG-CoA reductase inhibitor lovastatin or compactin at 10 microM) did not compromise cell viability but markedly suppressed
H2O2
generation. Under these conditions interleukin-8 (IL-8) production was attenuated (by 50-90%) in response to lipopolysaccharide,
granulocyte-macrophage colony-stimulating factor
, and phorbol myristate acetate. Coincubation of reductase inhibitor-treated cells with mevalonate prevented the attenuation of IL-8 production by reductase inhibitors. The effects of isoprenoid depletion on cytokine production were selective: IL-1 beta generation was not inhibited but the production of IL-6 and IL-8 was concomitantly suppressed. IL-8 induction was suppressed at least in part through attenuation of the increase in mRNA in stimulated cells. We conclude that isoprenoid generation through the mevalonate pathway is a requirement for IL-8 induction by activated monocytic cells in vitro. Isoprenylation inhibitors have the potential to alter monocyte proinflammatory function.
...
PMID:Role of the mevalonate pathway of isoprenoid synthesis in IL-8 generation by activated monocytic cells. 819 1
Single cytokine therapy with
granulocyte-macrophage colony-stimulating factor
(
GM-CSF
) or interleukin-3 (IL-3) has been shown to be effective in decreasing the respective periods of neutropenia and thrombocytopenia following radiation- or drug-induced marrow aplasia. The combined administration of IL-3 and
GM-CSF
in normal primates suggested that a sequential protocol of IL-3 followed by
GM-CSF
would be more effective than that of
GM-CSF
alone in producing neutrophils (PMN). We investigated the therapeutic efficacy of two combination protocols, the sequential and coadministration of recombinant human IL-3 and
GM-CSF
relative to respective single cytokine therapy, and delayed
GM-CSF
administration in sublethally irradiated rhesus monkeys. Monkeys irradiated with 450 cGy (mixed fission neutron:gamma radiation) received either IL-3,
GM-CSF
, human serum albumin (HSA), or IL-3 coadministered with
GM-CSF
for days 1 through 21 consecutively postexposure, or IL-3 or HSA for days 1 through 7 followed by
GM-CSF
for days 7 through 21. All cytokines and HSA were injected subcutaneously at a total dose of 25 micrograms/kg/d, divided twice daily. Complete blood counts (CBC) and platelet (PLT) counts were monitored over 60 days postirradiation. The respiratory burst activity of the PMN was assessed flow cytometrically, by measuring hydrogen peroxide (
H2O2
) production. Coadministration of IL-3 and
GM-CSF
reduced the average 16-day period of neutropenia and antibiotic support in the control animals to 6 days (P = .006). Similarly, the average 10-day period of severe thrombocytopenia, which necessitated PLT transfusion in the control animals, was reduced to 3 days when IL-3 and
GM-CSF
were coadministered (P = .004). The sequential administration of IL-3 followed by
GM-CSF
had no greater effect on PMN production than
GM-CSF
alone and was less effective than IL-3 alone in reducing thrombocytopenia. PMN function was enhanced in all cytokine-treated animals.
...
PMID:Combination protocols of cytokine therapy with interleukin-3 and granulocyte-macrophage colony-stimulating factor in a primate model of radiation-induced marrow aplasia. 821 92
To evaluate the effects of inflammatory cytokines on oxidative production in normal neutrophils, seven kinds of cytokines such as
granulocyte-macrophage colony-stimulating factor
(
GM-CSF
), granulocyte colony-stimulating factor (G-CSF), interleukin-2 (IL-2), IL-6, IL-1 alpha, IL-1 beta, and interferon-beta (IFN-beta) were tested. The intracellular hydrogen peroxide (
H2O2
) in individual cells was determined by flow cytometry. According to the levels of intracellular
H2O2
enhanced by cytokines, these seven cytokines were classified into three types: (1) prominently effective--
GM-CSF
; (2) moderately effective--G-CSF, IL-6, and IL-2; (3) weakly or ineffective--IFN-beta, IL-1 alpha, and IL-1 beta. Changes in cell size and cell surface structure after stimulation of those seven cytokines were simultaneously measured by flow cytometry. The most prominently effective cytokine,
GM-CSF
, initially caused enlargement of cell size and irregularity of the cell surface and subsequently increased
H2O2
production by neutrophils. In contrast, the weakly or ineffective cytokines, like IL-1 beta, had no effects on cell size or cell surface. Our study indicates that some kinds of cytokines enhance oxidative production and cause morphological changes in neutrophils.
...
PMID:An evaluation of the effects of cytokines on intracellular oxidative production in normal neutrophils by flow cytometry. 826 56
During a phase I trial of the genetically engineered hematopoietic growth factor PIXY321 (
granulocyte-macrophage colony-stimulating factor
/interleukin-3 [IL-3] fusion protein), we examined the effects of PIXY321 treatment on human polymorphonuclear leukocyte (PMN) locomotive, respiratory burst, and phagocytic responses. PIXY321 treatment was associated with transient suppression of both unstimulated locomotion and chemotaxis responses to multiple stimuli, as well as significant transient enhancement of formyl peptide-stimulated
H2O2
production. No effects on opsonic phagocytosis of Staphylococcus aureus were observed. In vitro exposure of control PMN to PIXY321 resulted in suppression of unstimulated locomotion/chemotaxis and enhancement of formyl peptide-stimulated
H2O2
production but had no effects on phagocytosis. When patient cells were exposed in vitro to PIXY321 during treatment, suppression of chemotaxis and enhancement of
H2O2
production were observed before PIXY321 treatment, but these effects diminished during treatment. The in vivo and in vitro exposure effects of PIXY321 treatment on PMN function are similar to those of the parent molecule,
granulocyte-macrophage colony-stimulating factor
(
GM-CSF
).
...
PMID:The effects of treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on human polymorphonuclear leukocyte function. 840 27
Apoptosis induced by wild-type p53 or cytotoxic compounds in myeloid leukemic cells can be inhibited by the cytokines interleukin 6, interleukin 3,
granulocyte-macrophage colony-stimulating factor
, and interferon gamma and by antioxidants. The antioxidants and cytokines showed a cooperative protective effect against induction of apoptosis. Cells with a higher intrinsic level of peroxide production showed a higher sensitivity to induction of apoptosis and required a higher cytokine concentration to inhibit apoptosis. Decreasing the intrinsic oxidative stress in cells by antioxidants thus inhibited apoptosis, whereas increasing this intrinsic stress by adding
H2O2
enhanced apoptosis. Induction of apoptosis by wild-type p53 was not preceded by increased peroxide production or lipid peroxidation and the protective effect of cytokines was not associated with a decrease in these properties. The results indicate that the intrinsic degree of oxidative stress can regulate cell susceptibility to wild-type p53-dependent and p53-independent induction of apoptosis and the ability of cytokines to protect cells against apoptosis.
...
PMID:Cellular oxidative stress and the control of apoptosis by wild-type p53, cytotoxic compounds, and cytokines. 879 72
One representative of a number of severe lesions that occur outside the glomerular capillaries and involve podocytes is crescentic glomerulonephritis. The question of whether the crescent-forming cells are derived from glomerular epithelial cells or monocytes/macrophages is highly controversial and has not yet been clarified. To investigate the pathophysiology of podocytes in crescentic glomerulonephritis, we attempted to establish methods for culturing cells confirmed to be derived from podocytes, focusing particularly on the relationship between podocytes and macrophages. Nonadherent cells of unknown origin that grew from normal rat isolated glomerular cultures increased in number, reaching a total of 3.5 x 10(5)/ml on Day 11. They showed several characteristics of macrophages, the expression of specific antigens and enzymes, morphology, and production of
H2O2
. They expressed Fx1A but lacked the expressions of Thy1.1 or factor VIII. A morphologic kinetic study on Days 3 to 11 of culture showed that the cells with foot processes on the glomerular basement membrane changed into macrophagic cells (MC) and migrated from the glomeruli. Immunofluorescence double staining indicated that the cells that migrated from the glomerular surface on Day 8 were both anti-podocalyxin- and ED-1-positive. Furthermore, immunoelectron microscopy revealed that the ED-1-positive cells were located on the glomerular basement membrane. Pretreatment with anti-macrophages and -Thy1.1 antibodies, both with complement, did not reduce the number of MC, whereas pretreatment with puromycin aminonucleoside predominantly reduced the number of MC. A predominant decrease in the number of glomerular macrophages by gamma-irradiation did not result in a reduction of the number of MC. MC derived from glomerular cultures of bone marrow chimeric rats expressed the la antigen originated from recipient, which indicates that MC is not derived from bone marrow cells. Macrophage colony-stimulating factor accelerated the speed of the change into MC, and
granulocyte-macrophage colony-stimulating factor
dramatically enhanced its degree with increase of cell number on Day 8. We concluded that podocytes change into MC in normal rat glomerular culture and that the change is enhanced by colony-stimulating factors. The results provide a completely new insight into the origin of crescent-forming cells.
...
PMID:Macrophagic cells outgrowth from normal rat glomerular culture: possible metaplastic change from podocytes. 894 Dec 17
TGF-beta1 and macrophages are important regulators of tissue fibrosis and remodeling. Here we show that TGF-beta1 induces the expression of macrophage-CSF (M-CSF) in vascular endothelial cells via a signaling pathway(s) involving hydrogen peroxide (
H2O2
). In a time-dependent manner, TGF-beta1 produced a 10- and a 6-fold increase in M-
CSF mRNA
and protein levels after 12 h, respectively. This increase in M-CSF expression was attenuated by a nitric oxide donor, S-nitrosoglutathione (GSNO), and by a nonspecific oxidase inhibitor, diphenylene iodonium. Furthermore, the TGF-beta1-induced M-
CSF mRNA
expression was inhibited by catalase, but not by superoxide dismutase, suggesting that
H2O2
rather than superoxide anion (O2.-) is the primary mediator of the effects of TGF-beta1. Transient transfection studies using deletional M-CSF promoter constructs demonstrated that TGF-beta1 produced a 13-fold induction in M-CSF promoter activity that was repressed by >85% with GSNO and catalase, in part through inhibitory effects on kappaB cis-acting elements. Electrophoretic mobility shift assays revealed that the activation of nuclear factor-kappaB by TGF-beta1 was also inhibited by GSNO and catalase, but not by superoxide dismutase. In a concentration-dependent manner, treatment with exogenous
H2O2
produced 14- and 4.6-fold increases in M-CSF promoter activity and mRNA expression, respectively. These results indicate that the generation of
H2O2
and activation of NF-kappaB by TGF-beta1 are required for the induction of M-CSF gene transcription.
...
PMID:Hydrogen peroxide-mediated transcriptional induction of macrophage colony-stimulating factor by TGF-beta1. 927 33
Endothelial cells (EC) produce cytokines, such as interleukin (IL)-1, IL-6, IL-8 and
granulocyte-macrophage colony-stimulating factor
(
GM-CSF
). These cytokines have an important role in the proliferation and differentiation of hematopoietic progenitor cells. On the other hand, anticancer agents generally cause hematopoietic disorders. However, little is known about the effects of chemotherapeutic agents on the secretion of cytokines from EC. Therefore, we investigated if treatment with platinum compounds may stimulate EC to secrete cytokines. EC newly isolated from a human umbilical vein were exposed to cisplatin, carboplatin, or TRK-710 for 80 min, then the cells were washed and placed in fresh medium. The levels of cytokines in the fresh medium were measured by the ELISA method, the levels of intracellular hydrogen peroxide (
H2O2
) were measured by flow cytometry, and the rhodamine 123-stained live mitochondria of the EC were observed under a confocal laser microscope. Platinum compounds induced cytokine production in human EC: cisplatin most prominently induced the release of IL-1 and IL-6, and TRK-710 had the greatest ability to induce the release of
GM-CSF
. Intracellular
H2O2
production and IL-8 release were transiently induced immediately after treatment with platinum compounds, leading to IL-1 release when
H2O2
production was eliminated. These results may provide new insights into the hematological toxicity induced by anticancer agents and the role of IL-1 and IL-6 secreted from EC in this toxicity.
...
PMID:Release of cytokines from human umbilical vein endothelial cells treated with platinum compounds in vitro. 973 83
In addition to their damaging effects, reactive oxygen intermediates exert a regulatory role on gene expression and cell apoptosis. In this study, we evaluated the effects of oxidative stress on human dendritic cells (DC), a cell type which is critical for the initiation of the immune response. For this purpose, we tested the effects of
H2O2
on DC derived from adherent peripheral blood mononuclear cells cultured in the presence of
granulocyte-macrophage colony-stimulating factor
and IL-4. Despite a moderate increase of DC apoptosis in the presence of
H2O2
, we observed that
H2O2
stimulated the production of IL-8 and TFN-alpha by DC in a dose-dependent manner. The induction of cytokine synthesis was found to depend on the oxidative properties of
H2O2
as it was inhibited by the addition of catalase, and to require de novo protein synthesis as it was not observed in the presence of cycloheximide. These data suggest that DC could contribute to innate immunity through an enhanced production of inflammatory cytokines in response to oxidative stress.
...
PMID:Oxidative stress up-regulates IL-8 and TNF-alpha synthesis by human dendritic cells. 984 32
Granulocyte-macrophage colony-stimulating factor
(
GM-CSF
)-transduced B16-F10 murine melanoma cells had lower tumorigenicity in both syngeneic and nude mice than parental or LacZ-transduced (control) cells. The subcutaneous (s.c.) tumors producing
GM-CSF
were densely infiltrated with macrophages, whereas the control tumors were not. In vitro studies showed that
GM-CSF
-transduced B16 cells were susceptible to lysis mediated by nonactivated murine macrophages, whereas control B16 cells were not. Macrophage-mediated cytotoxicity against
GM-CSF
-transduced B16 cells was independent of the presence of NO,
H2O2
, O2-, tumor necrosis factor alpha, and matrix metalloproteinase. Coculture experiments using
GM-CSF
-producing and -nonproducing B16 cells demonstrated that
GM-CSF
produced by the transduced B16 cells activated macrophages to kill the bystander non-
GM-CSF
-producing tumor cells. The results suggest that
GM-CSF
released by tumor cells can induce macrophage-mediated cytotoxicity, which in turn can inhibit the in vivo growth of
GM-CSF
-transduced tumor cells.
...
PMID:GM-CSF-transduced B16 melanoma cells are highly susceptible to lysis by normal murine macrophages and poorly tumorigenic in immune-compromised mice. 988 52
<< Previous
1
2
3
Next >>